Top Tech Companies in NYC, NY (10,000+)

Investor Backing & Capital Strength: Funding activity indicates renewed investor support, with $10 million raised in July 2026 toward a planned $32 million offering following a $28.1 million round in 2023. Cumulatively reported capital of roughly $52.9 million provides resources for rebuilding and expansion.

Market Expansion: Multi-state operations spanning Florida, Michigan, Ohio, Virginia, and Washington and a reported 45,000 attributed lives point to meaningful commercial reach. Company materials describe active launches and team-building across these markets.

Strategic Partnerships: Payer-oriented relationships, including a Carelon collaboration, align the model with health plans and community providers. These arrangements create distribution pathways to hard-to-reach populations within managed-care programs.

Strong Revenue Growth: Feedback suggests ARR expanded from an estimated $170M in 2024 to $250M in 2025, indicating roughly mid-to-high-40% growth at scale. Additional narrative points to multi-year acceleration supported by rising customer counts and product breadth.

Investor Backing & Capital Strength: Feedback suggests a $166M investment led by Salesforce in September 2026, with reports of valuation rising to around $3.2B. This capital indicates continued confidence to fund expansion and strategic initiatives.

Product Line Growth: Feedback suggests expansion beyond core HR into payroll and FP&A through acquisitions like Pento (2024) and Mosaic (2025). These moves broaden cross-sell potential and support upmarket motion.

Strong Revenue Growth: Reported fivefold year-over-year growth in 2025 and eight-figure ARR, with leadership describing double-digit month-over-month gains. The September 2026 financing materials also highlight 5× growth since the Series A.

Investor Backing & Capital Strength: A $55 million Series B in September 2026 led by Insight Partners brought total reported funding to $77 million, providing substantial resources for expansion. Independent coverage of the round underscores strong investor conviction.

Product Line Growth: The platform has expanded beyond cash application and deductions into trade promotion management, forecasting, demand planning, supply planning, and related workflows. Plans to extend into food service and scale AI capabilities indicate continued broadening of the offering.

Strong Revenue Growth: Estimated annualized net revenue rose from about $800 million in 2023 to roughly $1.2 billion in 2024, indicating substantial scaling. Earlier reporting also pointed to 2023 sales surpassing $800 million, reinforcing a multi‑year growth trajectory.

Profitability: Reporting indicates the business generated more than $10 million in monthly profits in 2025, suggesting growth paired with positive economics. While the company is private, these signals point to earnings strength alongside scale.

Market Expansion: Launching on Walmart.com in April 2026—and later availability on Amazon.com—extended distribution beyond the company’s own subscription channel. The 2026 acquisition of Woof further broadened its commercial footprint into adjacent pet‑care categories.

Market Expansion: Service availability is described across all 50 states with new local launches and roles dedicated to opening regional provider partnerships. This points to broadening geographic reach and distribution through healthcare and senior-care channels.

Product Line Growth: The platform has expanded beyond therapy to include healthcare advocacy, wellness classes, and AI-enabled care agents. These additions indicate a widening offering to address aging-related needs.

Strong Hiring & Retention: Active recruitment spans engineering, operations, analytics, revenue-cycle management, and provider-partnerships to scale care delivery. Such hiring momentum suggests investment in internal capacity to support larger patient and provider volumes.

Strong Revenue Growth: Global revenue increased to $60.2B in FY2026, with growth accelerating versus the prior year and all major service lines expanding. Asia Pacific and the Americas contributed most, though expansion was not uniform across regions.

Innovation-Driven Growth: Significant, multi‑billion investments are scaling AI and technology capabilities, alongside large‑scale AI upskilling across the workforce. Initiatives such as AI‑native assurance tools and the PwC One platform indicate a push to embed tech-enabled delivery.

Product Line Growth: New and expanded offerings in technology, consulting, strategy, and tax are being built through acquisitions and strategic investments. Within the latest year, Tax and Legal led growth, with Advisory and Assurance also advancing.

Strong Revenue Growth: Available reporting indicates ARR exceeded $600M by late 2025 and was estimated near $865M by mid-2026, pointing to rapid expansion of the subscription business. Company commentary notes growth acceleration in 2025 alongside higher-value plans and usage-based additions tied to AI.

Innovation-Driven Growth: Evidence suggests AI adoption is a major revenue driver, with a rising share of ARR linked to AI-enabled customers and swift uptake of new AI offerings such as agents. These capabilities appear to be prompting upgrades to premium tiers and expanding monetization beyond core workspace features.

Investor Backing & Capital Strength: An employee share tender at an $11B valuation with participation from existing and new investors indicates continued access to capital and confidence in the trajectory. Reports of cash-flow positivity further underscore financial resilience.

Resilient & Sustainable Growth: Reported assets under custody rose from $1 billion to more than $8 billion over five years, while advisor adoption expanded from nearly 800 firms in 2024 to more than 1,300 by September 2026. These milestones indicate sustained expansion in operating scale and distribution.

Product Line Growth: The offering has broadened beyond cash management into annuities and home lending, including the SoraFinance acquisition and the March 2026 launch of a mortgage solution. This expansion increases ways to serve existing advisor relationships and deepen platform engagement.

Investor Backing & Capital Strength: A definitive agreement announced in September 2026 would give Aquiline Capital Partners a controlling interest, with MassMutual retaining a significant stake. The planned transaction signals access to growth capital and institutional support, pending customary closing conditions.

Strong Revenue Growth: Trading revenue reached a record ~$12.2B in 2025, up about 25% from 2024, with record Q1 and Q2 2026 results reinforcing the trajectory. EBITDA also rose to roughly $6.5B, indicating earnings expansion alongside top-line growth.

Market Expansion: International hiring across six Asian markets in 2026 and a new Amsterdam office for European equity options point to deepening global reach and regional leadership builds. Senior appointments in EMEA and efforts to let Asian clients trade large U.S. equity blocks further extend coverage.

Product Line Growth: Launches in high-touch institutional equities and expansion in corporate bonds and fixed income broaden services beyond electronic market making. A venture tied to equity research (with Wolfe Research) adds new institutional capabilities and diversifies the offering.

Strong Revenue Growth: Sacra estimates indicate revenue rose from about $360M in 2023 to roughly $598M in 2024, a sharp increase attributed largely to Ro Body. This points to accelerated top-line momentum rather than mere product proliferation.

Market Expansion: Launches such as the nationwide Wegovy pill on January 5, 2026 and additional obesity-care offerings suggest broader reach across treatment categories and patient segments. Reuters also describes an influx of new customers with the oral Wegovy launch, including men who avoided injections.

Strategic Partnerships: Announcements document direct collaborations with Novo Nordisk on Wegovy and Eli Lilly on Zepbound, alongside a research tie-up with Amgen. These relationships expand access to branded therapies and reinforce distribution relevance in obesity care.

Strong Revenue Growth: Revenue is described as growing sharply year over year in 2024, with profitability reported at that time. This provides evidence of commercial momentum beyond user or customer counts.

Investor Backing & Capital Strength: Capital resources are reinforced by a sizable Series C led by a major investor at an increased valuation relative to 2021. This level of funding signals capacity to invest in scaling operations and product.

Market Expansion: Expansion includes the addition of flights and rental cars, acquisitions aimed at managed corporate travel, and a 2026 technology partnership with Navan. These moves broaden distribution and customer reach beyond the original hotel-booking focus.

Strong Revenue Growth: Afterpay-related revenue increased in Block’s latest reporting, with Afterpay Post-Purchase contributing higher year-over-year dollars in Q2 and the first half of 2026. Filings indicate the BNPL product is scaling within the parent company’s results.

Strong Market Position & Advantage: Independent estimates place Afterpay/Block in a leading position in U.S. BNPL issuance and Pay-in-4 lending. This standing suggests competitive advantage as the service expands into more everyday spending categories.

Customer Loyalty & Retention: Company materials describe the vast majority of gross merchandise value coming from returning customers. This repeat usage points to durable engagement across its merchant network.

Strong Revenue Growth: Revenue increased over recent fiscal years, with the latest results showing faster top-line momentum. Cloud sales expanded more quickly than the overall business, reinforcing this trajectory.

Customer Loyalty & Retention: Net revenue retention above 100% and rising subscription ARR indicate existing customers are expanding spend and renewing at healthy levels. Growth in higher-value cloud cohorts and larger contracted obligations add visibility.

Innovation-Driven Growth: Expansion into AI-assisted teamwork and enterprise service management is driving additional adoption and cross-sell alongside core products. Early traction for offerings like Rovo suggests multiple vectors beyond new-customer acquisition.

Product Line Growth: Successive releases such as LTX-2 and LTX-2.5, alongside an expanding suite spanning open-weight models, APIs, desktop tools, and a Studio platform, indicate active broadening of the offering. Feedback suggests this cadence is reinforcing adoption among developers, creators, and enterprise teams.

Market Expansion: Distribution and integrations through channels like Fal, Replicate, and ComfyUI, plus sustained activity on Hugging Face, point to widening reach. Feedback suggests these pathways lower adoption friction across developer and production workflows.

Investor Backing & Capital Strength: Leadership described an internal restructuring to separate LTX from Facetune and accelerate investment in AI video and enterprise creative tools. Feedback suggests this signals committed resources and strategic focus on scaling LTX.

Strong Revenue Growth: Reported ARR surpassed $200 million in June 2026 with five consecutive years of 100% year-over-year growth, indicating rapid scaling. Adoption breadth, including claims of powering one in six U.S. apartments, reinforces the commercial momentum behind that trajectory.

Investor Backing & Capital Strength: A $350 million round in September 2026 at a $4 billion valuation, with major existing investors participating alongside Ontario Teachers’ Pension Plan, underscores substantial access to capital. This financing signals strong confidence to fund continued product development and go-to-market expansion.

Market Expansion: Reach reportedly grew from about one in twelve U.S. apartments in 2024 to one in six in 2026, alongside plans for a second engineering hub in San Francisco. The company is also expanding from leasing into broader property-management workflows and healthcare administration.

Investor Backing & Capital Strength: Fund filings and regulatory data point to continued fundraising capacity and significant assets under management. A 2026 Form D for M13 Ventures V and reported AUM figures (e.g., $1.3B regulatory AUM and a separate $1.9B report) illustrate ongoing capital strength, even as definitions differ.

Innovation-Driven Growth: Recent investments in 2026 across AI and enterprise infrastructure—such as Rime, Baselayer, and Ayble Health—show active deployment into innovation-led areas. Portfolio companies securing follow-on capital and achieving outcomes like Prepared’s acquisition by Axon further suggest momentum tied to technology theses.

Strong Brand Reputation: Independent recognition, including a top-20 HEC Paris–Dow Jones VC Performance Ranking and inclusion on TIME’s Top 100 US VCs lists, signals strong standing. A portfolio featuring high-profile outcomes like Ring (acquired by Amazon) and Lyft reinforces visibility with founders and investors.

Strong Market Position & Advantage: Market share is increasing and reached a record in Q2 2026 even as the wider market softened. This points to rising competitiveness against other exchanges.

Diversified Revenue Streams: Subscription and services contributed nearly half of net revenue in Q2 2026, spanning stablecoins, staking, custody, and other services. Stablecoin balances such as USDC on Coinbase products also hit a company record, indicating income sources beyond spot trading.

Product Line Growth: New offerings like prediction markets grew sharply quarter over quarter in Q2 2026. Derivatives, equities, and decentralized-exchange products are scaling and broadening the revenue base.

Strong Revenue Growth: Revenue is rising at a mid-20s pace, with Q2 FY2027 up 26.2% year over year and FY2026 up 24.4%. Guidance was raised to approximately $910–$913 million, reinforcing near-term momentum.

Customer Loyalty & Retention: Net revenue retention is 110%, indicating existing customers expand spending overall. Enterprise adoption is deepening, with 361 customers at $500K+ ARR, up from 282 a year earlier.

Healthy Cash Flow: Free cash flow and operating cash flow improved meaningfully, including Q2 FY2027 free cash flow of $21.7 million versus $3.5 million a year earlier. Adjusted operating income also rose to $22.0 million in the quarter.

Investor Backing & Capital Strength: A $30 million Series B led by Andreessen Horowitz in February 2025 brought total funding to $50 million, with Axios independently reporting the round. This capital base supports continued hiring and expansion across product and go-to-market functions.

Market Expansion: The company reports expanding from behavioral health/ABA into physical therapy, ENT/allergy, and broader specialty care, and now serves 500+ providers across all 50 states. Year-end 2025 metrics also cite 81.8% growth in clinics and 163% growth in patients, and a 2026 acquisition added workflow automation expertise.

Innovation-Driven Growth: Platform capabilities are built on more than $2.5 billion in claims data with millions of claims processed, and reported a 12.3% year-over-year improvement in first-pass paid rate. These data- and automation-led workflows underpin scaling of claims across a nationwide footprint.

Strong Revenue Growth: Revenue is described as having surpassed the $1B mark with continued year-over-year increases into 2024. Evidence indicates momentum persisted through mid-2024, including higher run-rate revenue and rising bookings.

Product Line Growth: The platform broadened from websites into commerce, payments, financing, and AI-powered tools. Announcements in 2025–2026 indicate ongoing investment to deepen functionality for entrepreneurs and sellers.

Market Expansion: The absorption of Google Domains’ assets and millions of additional domains materially widened its funnel and recurring-services footprint. International investments, such as expanded operations in Ireland, further point to geographic scaling.